Skip to main content

Published locations for FDA grants ‘Breakthrough Therapy Designation’ for upadacitinib for atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA grants ‘Breakthrough Therapy Designation’ for upadacitinib for atopic dermatitis

User login

  • Reset your password
  • /content/fda-grants-breakthrough-therapy-designation-upadacitinib-atopic-dermatitis
  • /edermatologynews/article/156394/atopic-dermatitis/fda-grants-breakthrough-therapy-designation
  • /dermatology/article/156394/atopic-dermatitis/fda-grants-breakthrough-therapy-designation